Cardiopulmonary Exercise Testing and Preoperative Risk Stratification

NCT ID: NCT00737828

Last Updated: 2014-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

228 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-08-31

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators would like to evaluate the use of cardiopulmonary exercise tests (CPX) in guiding the care pathway of patients undergoing colorectal operations. In the intervention group care will be guided by CPX results and in the control group care will be guided by the doctors assessment. The investigators would like to assess the impact of this on patient outcome, patient satisfaction and resource usage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each year 20000 UK patients die within 30 days of surgery. It seems that in the UK a patient's chances of becoming seriously unwell or dying following surgery is higher than in comparable countries. Fewer beds in the UK are given over to Intensive Care than in these other countries. Closer attention to the care given after operations, which can be achieved on intensive care units (ICU), almost certainly reduces the chances of serious illness following major surgery. An increase in the number of intensive care unit beds in the UK is extremely unlikely. Better use of the available intensive care beds could be achieved by allocating them where they are believed to improve outcome (following surgery) and by allocating them to patients most likely to benefit.

Tests used to assess risk of surgery to patients are largely ineffective. Cardiopulmonary exercise tests (CPX) seem to be effective at identifying patients at risk of death or serious illness post surgery. This information has been used in studies to select patients for ICU beds and reduce deaths. The studies so far have limitations in their design and scope which means we can't be certain this approach works in the UK.

We suggest a study to answer this question more conclusively and more specifically in UK patients. We will randomly divide patients between two groups. In the 1st group choice of postoperative care environment is based on best current practice and in the other group we will make these decisions (critical care or ward) based on the results of the CPX.

We hope that the benefits will include less patients becoming seriously ill or dying and shorter stays in hospital after surgery following major operations. We also hope the information will help patients understand the risks of their operation better and therefore make better informed decisions. This may also reduce the overall cost of surgery for hospitals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Anaesthesia Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Control - Standard Perioperative Pathway, clinician decides post-operative care environment (usual care)

Group Type ACTIVE_COMPARATOR

Perioperative care pathway guided by CPX results

Intervention Type OTHER

* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure

B

Intervention - Perioperative care pathway guided by CPX Results i.e.anaerobic threshold \& ventilatory equivalents

Group Type EXPERIMENTAL

Perioperative care pathway guided by CPX results

Intervention Type OTHER

* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Perioperative care pathway guided by CPX results

* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults ≥ 18 years age
2. Males
3. Females
4. Listed for elective(non-emergency) colorectal surgery

Exclusion Criteria

1. Age \< 18 years age
2. Patient unwilling/unable to consent
3. Adults with learning disabilities or dementia
4. Prisoners
5. Any contraindication to cardiopulmonary exercise testing (as outlined by \*American Association of Anaesthesia:

* Acute MI (3-5 days)
* Unstable angina
* Uncontrolled arrhythmias
* Syncope
* Acute endocarditis
* Acute myocarditis
* Acute pericarditis
* Symptomatic severe aortic stenosis
* Uncontrolled heart failure
* Acute pulmonary embolism or infarction
* Thrombosis of lower extremities
* Dissecting aneurysm
* Uncontrolled asthma
* Pulmonary oedema
* Room air desaturation at rest \<85%
* Respiratory failure
* Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise Mental impairment leading to inability to co-operate
6. Patients already enrolled in an interventional study
7. Previous CPX test result recorded in the medical notes
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Southampton NHS Foundation Trust

OTHER

Sponsor Role collaborator

University College London Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mike Grocott

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael PW Grocott

Role: STUDY_DIRECTOR

University College, London

Paula Meale

Role: PRINCIPAL_INVESTIGATOR

University College, London

Michael Mythen

Role: PRINCIPAL_INVESTIGATOR

University College, London

Ayo Oshowo

Role: PRINCIPAL_INVESTIGATOR

Whittington Hospital NHS Trust

Mervyn Singer

Role: PRINCIPAL_INVESTIGATOR

University College, London

Geoff Bellingan

Role: PRINCIPAL_INVESTIGATOR

University College London Hospitals

Kay Mitchell

Role: PRINCIPAL_INVESTIGATOR

University College, London

Hasan Muktar

Role: PRINCIPAL_INVESTIGATOR

The Whittington Hospital Hospital NHS Trust

Alistair Windsor

Role: PRINCIPAL_INVESTIGATOR

University College London Hospitals

Jim Down

Role: PRINCIPAL_INVESTIGATOR

University College London Hospitals

Martin B Kuper

Role: PRINCIPAL_INVESTIGATOR

Whittington Hospital NHS Trust

Denny ZH Levett

Role: PRINCIPAL_INVESTIGATOR

University College, London

Phil Hennis, PhD

Role: PRINCIPAL_INVESTIGATOR

UCL

Alasdair O'Doherty, MSc

Role: PRINCIPAL_INVESTIGATOR

UCL

Alec Engledow

Role: PRINCIPAL_INVESTIGATOR

UCLH

Aundrea Mulreany

Role: PRINCIPAL_INVESTIGATOR

Whittington Hospital

Carolyn Dr Way

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Karen Linford

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Clare Bolger

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Paul Nichols

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Kim Golder

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

John S Knight

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Michael Celinski

Role: PRINCIPAL_INVESTIGATOR

University Hospital Southampton NHS Foundation Trust

Grace Adesina

Role: PRINCIPAL_INVESTIGATOR

University College London Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Whittington Hospital NHS Trust

London, , United Kingdom

Site Status

University College London Hospitals NHS Foundation Trust

London, , United Kingdom

Site Status

Southampton University Hospitals NHS Trust

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07/H0716/55

Identifier Type: OTHER

Identifier Source: secondary_id

PB-PG-0906-11426

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

07/0114

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Perioperative UtiLisation of SupplEmental Oxygen
NCT03552627 ACTIVE_NOT_RECRUITING PHASE4